Tim there is no financial Impact on Shine. They have one the first case, this matter is now resolved and they have been paid in full. There will not be much more costs involved in the appeal as it is most likely a stalling tactic by J&J as played out many times at this level. I am not sure if they will continue to self fund or externally fund but a fully run appeal will be a fraction of the initial case, a few million at best. J&J is actually a huge asset to SHJ more than has been let on. If they win or J&J settles before the matter is heard, it will bring about millions in administrations costs over the next few years, that is lawyer rates without any risk element whatsover.
- Forums
- ASX - By Stock
- SHJ
- Ann: Appendix 4D and FY21 Half Year Financial Statements
Ann: Appendix 4D and FY21 Half Year Financial Statements, page-19
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
86.0¢ |
Change
-0.015(1.71%) |
Mkt cap ! $148.9M |
Open | High | Low | Value | Volume |
86.0¢ | 86.0¢ | 86.0¢ | $2.19K | 2.546K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8488 | 86.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
87.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8488 | 0.860 |
1 | 10000 | 0.850 |
1 | 10000 | 0.810 |
2 | 3474 | 0.800 |
1 | 948 | 0.740 |
Price($) | Vol. | No. |
---|---|---|
0.870 | 10000 | 1 |
0.875 | 348 | 1 |
0.880 | 3410 | 1 |
0.890 | 44140 | 1 |
0.900 | 25834 | 3 |
Last trade - 15.58pm 12/11/2024 (20 minute delay) ? |
Featured News
SHJ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online